Veracyte

VCYT71

$37.04arrow_drop_down6.24%-$2.46

VCYT71

$37.04

arrow_drop_down6.24%-$2.46

Performance History

Key Stats
Open	$39.53
Prev. Close	$39.53
EPS	-0.13
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	38.37	39.87
52 Week Range	18.61	41.18

Ratios







EPS	-0.13

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Veracyte (VCYT)

Veracyte Inc (VCYT) is a molecular diagnostics company that develops and markets genomic diagnostic tests to improve patient care. The company's molecular tests enable healthcare providers to make informed decisions regarding patient diagnosis, treatment, and monitoring. Veracyte Inc was founded in 2008 and is headquartered in South San Francisco, California. The company's stock is traded on the Nasdaq Global Market under the ticker symbol VCYT.

Veracyte Inc has been steadily growing over the years, with its stock price reaching new highs. The company's stock price history shows a consistent upward trend, reflecting the market's confidence in its products and services. The stock has experienced some fluctuations, but overall, it has performed well. Investors who purchased Veracyte Inc stock have seen significant returns on their investments.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Marc A. Stapley
Headquarters: South San Francisco
Employees: 787
Exchange: NASDAQ

Keep an eye on Veracyte

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Veracyte 's (VCYT) price per share?

The current price per share for Veracyte (VCYT) is $37.04. The stock has seen a price change of -$2.47 recently, indicating a -6.25% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Veracyte (VCYT)?

For Veracyte (VCYT), the 52-week high is $41.18, which is 11.18% from the current price. The 52-week low is $18.61, the current price is 99.03% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Veracyte (VCYT) a growth stock?

Veracyte (VCYT) has shown an average price growth of -3.55% over the past three years. It has received a score of 51 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Veracyte as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Veracyte (VCYT) stock price performance year to date (YTD)?

As of the latest data, Veracyte (VCYT) has a year-to-date price change of 35.18%. Over the past month, the stock has experienced a price change of 9.17%. Over the last three months, the change has been 13.79%. Over the past six months, the figure is 64.62%. Looking at a longer horizon, the five-year price change stands at 53.5%.

help

Is Veracyte (VCYT) a profitable company?

Veracyte (VCYT) has a net income of -$74.4M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 61.81% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 10.53% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $361.05M, with a revenue growth rate of 21.76%, providing insight into the company's sales performance and growth. The gross profit is $223.15M. Operating income is noted at -$85.8M. Furthermore, the EBITDA is $45.91M.

help

What is the market capitalization of Veracyte (VCYT)?

Veracyte (VCYT) has a market capitalization of $3.06B. The average daily trading volume is 37.53, indicating the stock's liquidity and investor engagement.